Literature DB >> 27123495

Adult Stem Cells and Diabetes Therapy.

Handenur Ilgun1, Joseph William Kim2, LuGuang Luo2.   

Abstract

The World Health Organization estimates that diabetes will be the fourth most prevalent disease by 2050. Developing a new therapy for diabetes is a challenge for researchers and clinicians in field. Many medications are being used for treatment of diabetes however with no conclusive and effective results therefore alternative therapies are required. Stem cell therapy is a promising tool for diabetes therapy, and it has involved embryonic stem cells, adult stem cells, and pluripotent stem cells. In this review, we focus on adult stem cells, especial human bone marrow stem cells (BM) for diabetes therapy, its history, and current development. We discuss prospects for future diabetes therapy such as induced pluripotent stem cells which have popularity in stem cell research area.

Entities:  

Keywords:  Bone marrow; Diabetes; Induced pluripotent stem cells; Islet β-cell; Stem cell therapy

Year:  2015        PMID: 27123495      PMCID: PMC4844026     

Source DB:  PubMed          Journal:  J Stem Cell Res Transplant


  26 in total

Review 1.  beta-Cell death during progression to diabetes.

Authors:  D Mathis; L Vence; C Benoist
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury.

Authors:  Vikram Mathews; Piia T Hanson; Eric Ford; Jun Fujita; Kenneth S Polonsky; Timothy A Graubert
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

Review 3.  Marrow stromal cells: implications in health and disease in the nervous system.

Authors:  Mari Dezawa; Mikio Hoshino; Yo-ichi Nabeshima; Chizuka Ide
Journal:  Curr Mol Med       Date:  2005-11       Impact factor: 2.222

4.  Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes.

Authors:  Li-Xue Guan; Hui Guan; Hai-Bo Li; Cui-Ai Ren; Lin Liu; Jin-Jin Chu; Long-Jun Dai
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

5.  Allogeneic bone marrow cocultured with human islets significantly improves islet survival and function in vivo.

Authors:  John Z Q Luo; Fang Xiong; A Samer Al-Homsi; Camillo Ricordi; Luguang Luo
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

6.  Transdifferentiation of Bone Marrow Mesenchymal Stem Cells into the Islet-Like Cells: the Role of Extracellular Matrix Proteins.

Authors:  Marta Pokrywczynska; Marzena Anna Lewandowska; Sandra Krzyzanowska; Arkadiusz Jundzill; Marta Rasmus; Karolina Warda; Maciej Gagat; Aleksander Deptula; Anna Helmin-Basa; Marcin Holysz; Maciej Nowacki; Lukasz Buchholz; Magdalena Bodnar; Andrzej Marszalek; Alina Grzanka; Wojciech Jozwicki; Jacek Michalkiewicz; Tomasz Drewa
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-05-10       Impact factor: 4.291

7.  Generation of insulin-secreting islet-like clusters from human skin fibroblasts.

Authors:  Keisuke Tateishi; Jin He; Olena Taranova; Gaoyang Liang; Ana C D'Alessio; Yi Zhang
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  Generation of pluripotent stem cells from patients with type 1 diabetes.

Authors:  René Maehr; Shuibing Chen; Melinda Snitow; Thomas Ludwig; Lisa Yagasaki; Robin Goland; Rudolph L Leibel; Douglas A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

9.  Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice.

Authors:  Sudhanshu P Raikwar; Eun-Mi Kim; William I Sivitz; Chantal Allamargot; Daniel R Thedens; Nicholas Zavazava
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

10.  Anti-apoptotic Effects of Bone Marrow on Human Islets: A Preliminary Report.

Authors:  Lu-Guang Luo; John Zq Luo
Journal:  J Stem Cell Res Ther       Date:  2015-04
View more
  5 in total

Review 1.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

Review 2.  Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.

Authors:  Hyunyun Kim; Sujin Kim; Sang Hong Baek; Sang-Mo Kwon
Journal:  Stem Cells Int       Date:  2016-12-20       Impact factor: 5.443

Review 3.  Intra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation.

Authors:  Siddharth Narayanan; Gopalakrishnan Loganathan; Maheswaran Dhanasekaran; William Tucker; Ankit Patel; Venugopal Subhashree; SriPrakash Mokshagundam; Michael G Hughes; Stuart K Williams; Appakalai N Balamurugan
Journal:  World J Transplant       Date:  2017-04-24

Review 4.  Metabolomics and Cell Therapy in Diabetes Mellitus.

Authors:  Bagher Larijani; Parisa Goodarzi; Moloud Payab; Sepideh Alavi-Moghadam; Fakher Rahim; Nikoo Bana; Mina Abedi; Maryam Arabi; Hossein Adibi; Kambiz Gilany; Babak Arjmand
Journal:  Int J Mol Cell Med       Date:  2019-05-30

5.  Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.

Authors:  Mairvat Al- Mrahleh; Suzan Matar; Hanan Jafar; Suha Wehaibi; Nazneen Aslam; Abdalla Awidi
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.